Overview

AGN-229666 Ophthalmic Solution for the Treatment of Seasonal or Perennial Allergic Conjunctivitis

Status:
Completed
Trial end date:
2014-07-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the safety and efficacy of AGN-229666 for the treatment of seasonal or perennial allergic conjunctivitis.
Phase:
Phase 3
Details
Lead Sponsor:
Allergan
Treatments:
Ophthalmic Solutions